|
**Overview**: Allergy Animal Panel**Introduction**: The Allergy Animal Panel is a diagnostic tool designed to screen for animal allergies using serum samples. In India, animal dander sensitization contributes to allergic rhinitis and asthma, with prevalence ~2-10% in sensitized cohorts (higher in urban/pet-owning households amid rising pet trends). Studies show low clinical prevalence (e.g., 2.8% report animal contact precipitation), but sensitization is notable in multi-allergen exposed individuals, often co-occurring with dust mite dominance. Presents with rhinitis, asthma exacerbations, conjunctivitis, skin reactions. High morbidity from underdiagnosis in children/adults with pet exposure, limited testing in rural areas. Per immunology practices (aligned ICMR guidelines), the test employs immunoassay for detailed parameter analysis over 1-2 days with high sensitivity/specificity, making it valuable for screening in rhinitis/asthma patients. This diagnostic falls under allergy screening and targets individuals with suspected animal allergies, addressing the challenge of accurate trigger detection to guide avoidance and treatment. With morbidity elevated due to underdiagnosis in urbanizing populations, the test supports public health efforts by enabling precise identification, facilitating management, and reducing complications. Its serum-based approach ensures reliable detection.**Other Names**: Allergy Animal Pnl.**FDA Status**: FDA approved, CLIA certified for immunology, compliant with 2025 standards.**Historical Milestone**: Expanded with specific IgE testing; in India, relevance with increasing urban pet ownership.**Purpose**: The test screens for 4 parameters including cat dander to guide animal allergy assessment, identify specific triggers, and inform avoidance/treatment strategies in pet-exposed populations.**Test Parameters**: 1. Cat Dander IgE, 2. Dog Dander IgE, 3. Horse Dander IgE, 4. Cow Dander IgE.**Pretest Condition**: No fasting required; patients should report rhinitis, asthma, eye/skin symptoms after animal exposure.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on pet exposure, symptoms post-contact, family allergy history, or urban/rural living.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of untreated allergies including chronic rhinitis/asthma, benefits of early detection, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using immunoassay by trained personnel to ensure sterile technique, avoid contamination, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols, and store kits according to manufacturer specifications to ensure reliability.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis, or cross-reactivity can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Abnormal results indicate possible animal allergy, necessitating further investigation like specialist consultation or additional testing. Normal results may require follow-up if symptoms persist.**Specialist Consultation**: Allergists or general practitioners should be consulted for case management, avoidance planning, and coordination with health programs.**Additional Supporting Tests**: Skin prick test, symptom diary for confirmation.**Test Limitations**: The test may produce false negatives in low exposure or false positives in sensitization without clinical allergy, requiring a comprehensive diagnostic approach that includes clinical correlation.**References**: Indian Journal Allergy Asthma 2024, NFHS Allergen Studies 2023. |
